Fact checked by Nick Blackmer Eli Lilly’s Zepbound bested Novo Nordisk’s Wegovy in the first head-to-head trial comparing ...

Hundreds of vials of black-market weight loss drugs have been seized from a home and two clinics in West Tennessee.

The European Medicines Agency has allowed Eli Lilly to update the product label of its weight-loss drug Mounjaro to show it ...

The most common adverse events reported with both treatments were mild to moderate gastrointestinal-related side effects.

A Medina woman was arrested for allegedly selling black market weight loss drugs to local clinics and other individuals in ...

The woman selling the illegal black market weight loss drugs not only sold them out of her home, but supplied the drugs to ...

Data continue to show that tirzepatide, called Mounjaro for type 2 diabetes and Zepbound for weight loss, is safe and effective, but side effects remain.

Patients lost an average of 20.2% of their weight with tirzepatide over 72 weeks versus 13.7% with semaglutide.

GP leaders have warned that the rollout of the weight loss drug tirzepatide (Mounjaro, Eli Lilly) will still have ...

US: Sharing the topline results from the SURMOUNT-5 phase 3b open-label randomized clinical trial, Eli Lilly and Company ...

Tirzepatide has been shown in clinical trials to be more effective than diet and exercise support alone, and when compared ...

Eli Lilly and Company (NYSE: LLY) today announced topline results from the SURMOUNT-5 phase 3b open-label randomized clinical ...